as on February 6, 2026 at 2:09 pm IST
Day's Low
Day's High
0.67%
Downside
0.61%
Upside
52 Week's Low
52 Week's High
9.70%
Downside
33.32%
Upside
as on February 6, 2026 at 2:09 pm IST
Market Cap
₹2,035.76 Cr
Return on Equity (ROE)
13.19
PE Ratio (TTM)
0Return on capital employed (ROCE)
16.64
Beta (LTM)
0.48
P/B Ratio
2.47
Dividend Yield
0PEG Ratio
0Quarterly Earnings Growth YOY
-36.78
EPS (TTM)
0Sector
Pharmaceuticals
Book Value
0Technical Analysis
Bullish
View Technical Analysis
Compare market cap, revenue, PE, and other key metrics of Novartis India with its industry peers.
Company | Analyst View | Market Cap(in ₹ Cr) | 5 Year CAGR | Debt to Asset Ratio | Net Profit(in ₹ Cr) | Yearly Revenue(in ₹ Cr) |
|---|---|---|---|---|---|---|
| NA | 2,035.76 | 5.07% | 0.00 | 100 | 390 | |
| NA | 8.45 | -15.3% | 0.51 | -6 | 22 | |
| BUY | 17,127.68 | 1.21% | 0.58 | 170 | 1,694 | |
| NA | 2,278.53 | 16.07% | 0.53 | -9 | 559 | |
| NA | 61.08 | -11.1% | 0.00 | 1 | 33 |
Get share price movements and forecasts by analysts on Novartis India.
Source: S&P Global Market Intelligence
Search interest for Novartis India Ltd Stock has increased by 78% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:78% versus previous 30 day period
Figures in Rupees Crores
Figures in Rupees Crores
Figures in Rupees Crores
View detailed summary of the earnings and dividend history of Novartis India.
Novartis India Ltd’s net profit fell -36.78% since last year same period to ₹16.09Cr in the Q3 2025-2026. On a quarterly growth basis, Novartis India Ltd has generated -33.57% fall in its net profits since last 3-months.
Read More about Earnings ResultsIn the quarter ending March 2025, Novartis India Ltd has declared dividend of ₹25.00 per share on 09 May 2025 - translating a dividend yield of 6.04%.
Read More about DividendsCheck stock indices that include Novartis India.
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Price Rise
![]()
In the last 7 days, NOVARTIND stock has moved up by 8.6%
FII Holding Unchanged
![]()
Foreign Institutions holdings remained unchanged at 0.19% of holdings in Dec 2025 quarter
Promoter Holding Unchanged
![]()
Promoters holdings remained unchanged at 70.68% of holdings in Dec 2025 quarter
Against Peers
![]()
In the last 3 years, Torrent Pharmaceuticals Ltd has given 157.6% return, outperforming this stock by 126.8%
Against Peers
![]()
In the last 1 year, Torrent Pharmaceuticals Ltd has given 25.8% return, outperforming this stock by 30.8%
Retail Holding Down
![]()
Retail Investor have decreased holdings from 28.60% to 28.50% in Dec 2025 quarter
| Organisation | Novartis India Ltd |
| Headquarters | Mumbai |
| Industry | Pharmaceuticals |
| CEO | C Snook |
| E-voting on shares | Click here to vote |
Novartis India share price today stands at ₹825 as on . Novartis India share today touched a day high of ₹830 and a low of ₹819.5.
Novartis India touched a 52 week high of ₹1099.9 and a 52 week low of ₹744.95. Novartis India share price today i.e. is trending at ₹825, which is -24.99% down from its 52 week high and 10.75% up from its 52 week low.
Novartis India market capitalisation is ₹2,035.76 Cr as on .
To buy Novartis India shares, you need to follow these steps:
Novartis India trading volume is 5,719.00 as on . This means that 5,719.00 shares of Novartis India were bought and sold on the stock market during today's trading session.